Recent News for GBT - Global Blood Therapeutics, Inc.

Date Title
Mar 22 Today’s Research Reports on Trending Tickers: Global Blood Therapeutics and Sangamo Therapeutics
Mar 21 Turning Neutral: Morgan Stanley Downgrades Sarepta, Loxo Oncology, Global Blood Therapeutics
Mar 21 Why Global Blood Therapeutics (GBT) Could Be Positioned for a Slump
Mar 21 Premarket analyst action - healthcare
Mar 15 Better Know Biotech: 3 Highfliers That Ought to Be on Your Radar
Mar 14 Research Report Identifies Supernus Pharmaceuticals, Celestica, Global Blood Therapeutics, BioTime, CyberArk Software, and Tivity Health, Inc. with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
Mar 12 5 Stocks That Are Showing Signs of Reversing
Mar 12 Global Blood Therapeutics Announces Full Exercise of Underwriter’s Option to Purchase Additional Shares
Mar 9 Global Blood prices $216M stock offering at $54; shares down 4% premarket
Mar 9 Global Blood Therapeutics Announces Pricing of Public Offering of 4,000,000 Shares of Common Stock
Mar 9 Is Global Blood Therapeutics Inc’s (NASDAQ:GBT) Liquidity As Good As Its Solvency?
Mar 8 After Hours Gainers / Losers (3/8/2018)
Mar 8 Global Blood launches 3.5M-share stock offering
Mar 6 GBT Appoints Industry Leader David L. Johnson as Chief Commercial Officer
Mar 5 GBT Announces Participation at Upcoming Investor Conferences in March
Mar 5 GBT Announces New Employment Inducement Grants
Feb 28 Global Blood reports 4Q loss
Feb 27 Global Blood Therapeutics misses by $0.23
Feb 27 GBT Reports Recent Business Progress and Fourth Quarter and Year-End 2017 Financial Results
Feb 26 This could be the next $1 billion drug, if patients get on board
Feb 15 With an Eye on Biotech, Here's Today's Trading Thesis
Feb 14 Benzinga's Top Upgrades, Downgrades For February 14, 2018
Feb 7 GBT Announces Participation at the Leerink Partners 7th Annual Global Healthcare Conference
Feb 7 The Confidence in the Dip Buyers Has Weakened
Feb 5 Here's Why Global Blood Therapeutics Inc. Soared 47.1% in January
Back to the Main GBT Page...